Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Aruba Aruba
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Comment by mba123ccuon Dec 13, 2021 9:04am
156 Views
Post# 34224380

RE:RE:Aruba Aruba

RE:RE:Aruba Aruba
Nailbiter1 wrote: Tourism is the mainstay of Aruba's economy. Approximately two million tourists per year visit Aruba, nearly 80 percent of those coming from the United States.

It's also where James goes to take a break from Barbados.


"COVID-19 testing requirements are key to keeping people safe, but they can be difficult for travelers to navigate when planning a trip abroad, especially now with the new Omicron variant," said James Howard-Tripp, Chairman and CEO of StageZero. "By joining forces with OK2Roam and VSF Global we can significantly reduce the stress and worry of this process for people visiting Aruba from Canada and the U.S. by providing them with a simple and trusted testing solution that delivers reliable results rapidly."

With new variants croping up, testing is becoming even more important and seems will be here for a long time, so good for SZLS to expand there market - progress SZLS.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities